-+ 0.00%
-+ 0.00%
-+ 0.00%

Revelation Biosciences Q2 EPS $(0.87) Beats $(0.88) Estimate

Benzinga·08/06/2026 21:18:09
Listen to the news
Revelation Biosciences (NASDAQ:REVB) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(0.88) by 1.14 percent. This is a 87.59 percent increase over losses of $(7.01) per share from the same period last year.